Preclinical models of multiple sclerosis in nonhuman primates

Area of Science:

• Biotechnology and immunology
• Neuroscience
• Translational medicine

Background:

• Biologics offer targeted therapies for immune-mediated inflammatory disorders (IMIDs).
• High species specificity of these therapies limits testing in traditional animal models like mice and rats.
• There is a critical need for advanced experimental models in nonhuman primates (NHPs) for IMID research.

Purpose of the Study:

• To review the development of nonhuman primate (NHP) models for studying multiple sclerosis (MS), a central nervous system IMID.
• To discuss the utility of NHP models in advancing MS research and therapy development.
• To explore how NHP models facilitate the translation of scientific principles into clinical applications for MS.

Main Methods:

• Review of existing literature on NHP model creation for IMIDs.
• Analysis of the relevance of NHP models for multiple sclerosis research.
• Discussion of translational strategies using NHP models.

Main Results:

• NHP models are essential for evaluating the safety and efficacy of biologics targeting IMIDs, including MS.
• These models address the limitations of using rodents for species-specific therapies.
• The development of relevant NHP models is key for advancing MS therapeutics.

Conclusions:

• Nonhuman primate models are indispensable for the development of targeted therapies for immune-mediated inflammatory disorders like multiple sclerosis.
• These models bridge the gap between preclinical research and clinical application for MS.
• Effective NHP models are vital for the successful translation of novel scientific principles into MS treatments.